The Effect Of Methylphenıdate Treatment On Neuroınflammatıon Levels In Chıldren Wıth Attentıon Defıcıt Hyperactıvıty Dısorder
The aim of this study was to investigate the effect of treatment of ADHD with methylphenidate on neuroinflammation by examining the levels of Interleukin-6 (IL-6), S100B, Claudin-5 in serum samples of patients who were diagnosed with attention deficit hyperactivity disorder (ADHD) and started or planned to start methylphenidate for treatment as per routine, at month 0 before the initiation of methylphenidate treatment and at month 3 after the initiation of treatment.
• According to DSM-5 TR, the participant must have a diagnosis of Attention Deficit Hyperactivity Disorder and have started/be planning to start routine methylphenidate treatment.
• The participant must be between 6 and 11 years of age.
• The participant must agree to participate in the study after being informed about it.